The field of organ-on-a-chip has been in existence for 20 years, with the pace of commercialization increasing significantly in the past 5 years. CN Bio Innovations have commercialized single and multi-organ chips based on technology from the lab of Prof L. Griffith at M.I.T. Liver and liver disease models are an attractive target for organ-on-a-chip technologies owing to the relatively rapid dedifferentiation of primary liver cells in 2D culture. In this presentation I will discuss the development and commercialization of CN Bio Innovation’s LiverChip platform together with Quantum B our full viral life cycle model of Hepatitis B infection and look ahead to opportunities for multi-organ systems.
Recommended Videos
LC-MS/MS for Bioanalytical Peptide and Protein Quantification: MS Considerations
VideoCaitlin Dunning, Associate Scientist, discusses how to use mass spectrometry to develop sensitive, selective, and robust quantification methods for peptide and protein quantification, including: basic mass spectrometry considerations, MS tuning, and best practices for success.
WATCH NOWNow you can visualize and analyze complex 3D cell models – with Harmony 4.8 software
VideoSee what you’re missing with the new capabilities of Harmony® 4.8 software for imaging, analysis, and visualization of complex 3D cell models.
WATCH NOWContrasting LBAs and LC-MS for Peptide and Protein Bioanalysis
VideoKelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS.
WATCH NOWComments | 0 ADD COMMENT
Like what you just watched? You can find similar content on the communities below.
Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
Login
You must be logged in to post a comment.